To include your compound in the COVID-19 Resource Center, submit it here.

Apitope, Merck KGaA deal

Merck KGaA's Merck Serono S.A. subsidiary received exclusive, worldwide rights to develop and commercialize Apitope's

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE